A5034191531- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- RNA modifications and cancer
- Lipid metabolism and disorders
- Liver Disease and Transplantation
Ain Shams University
2021-2025
<title>Abstract</title> Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that primarily affects the colon and rectum. It characterized by recurrent episodes of inflammation ulceration in lining colon. UC considered one two major types IBD, with other being Crohn's disease. This study aimed to investigate relationship between Serum Syndecan-1 levels activity patients UC. Patients Methods: observational cross-sectional included 84 participants; those were...
<title>Abstract</title> <bold>Background: </bold>Incidence of Hepatocellular carcinoma (HCC) has increased over the past few decades to become most common primary hepatic malignancy. Most patients with HCC have advanced unresectable disease, resulting in limited treatment options curative intent and poor survival outlooks<bold>.</bold> <bold>Results:</bold> In this study on Egyptian patients, hepatocellular primarily occurred sixth decade life, often alongside liver cirrhosis. No significant...
<title>Abstract</title> <bold>Background: </bold>Hepatocellular carcinoma (HCC) is the sixth prevailing cancer globally and second greatest reason for cancer-linked deaths in males, surpassed only by lung cancer. A significant number of HCC cases experiencing advanced stages are due to frequent absence or inconspicuousness early symptoms. Consequently, discovering reliable diagnostic indicators innovative treatment targets essential improve survival overall outcomes patients. Herein, we...
Abstract Background Hepatocellular carcinoma (HCC) is the sixth prevailing cancer globally and second greatest reason for cancer-linked deaths in males, surpassed only by lung cancer. A significant number of HCC cases experiencing advanced stages are due to frequent absence or inconspicuousness early symptoms. Consequently, discovering reliable diagnostic indicators innovative treatment targets essential improve survival overall outcomes patients. Herein, we aimed evaluate potential APEX1...
Abstract Background Non-alcoholic fatty liver disease remains asymptomatic until advanced disease, when risk factor modification and available treatment become no longer effective. Studies on hepatic vasculature can be informative about parenchymal injury severity through the study of changes affecting vascular compliance. This aimed to portal vein artery hemodynamic variation in non-alcoholic correlate it with severity. Results case control included 80 participants; those were further...